EP0031, Platinum chemotherapy, Pemetrexed — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancie
Phase 1/2 · NSCLC |
Ellipses Pharma | EP0031, Platinum chemotherapy, Pemetrexe |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-31
Sponsor-projected date — can change
|